Tech Company Financing Transactions
AusperBio Funding Round
AusperBio secured a $73 million Series B funding round on 12/26/2024. Investors included Hankang Capital, CDH Investments and InnoPinnacle Fund.
Transaction Overview
Company Name
Announced On
12/26/2024
Transaction Type
Venture Equity
Amount
$73,000,000
Round
Series B
Investors
Proceeds Purpose
The proceeds will fund the continued Phase 2 development of AHB-137, AusperBio's lead investigational therapy, supporting both clinical studies in China and global trials, as well as the development of commercial-scale manufacturing processes. The funding will also facilitate the expansion of the company's therapeutic pipeline and operational capabilities to drive sustained growth.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
3 E. 3rd Ave 200
San Mateo, CA 94401
USA
San Mateo, CA 94401
USA
Phone
Website
Email Address
Overview
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing oligonucleotide therapeutics. Leveraging our innovative and proprietary Med-Oligo� ASO platform with effective targeted delivery technologies, we strive to unleash the power of ASO therapeutics to treat a wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases, and to transform patient lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Guofeng Cheng
Chief Operating Officer
Suyun Xu
Chief Scientific Officer
Chris Yang
Vice President
Hengxu Wei
VP - Bus. Development
Miao Wang
VP - Bus. Development
Xuetao Wen
VP - R & D
Yang Tian
Browse more venture capital transactions:
Prev: 12/26/2024: Northwest Biotherapeutics venture capital transaction
Next: 12/27/2024: Vitalic venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs